Insight
Telehealth Transformation: Innovating Mental Health Care
Life Sciences Snapshot – Q1 2025
11 minute read | February.19.2025

11 minute read | February.19.2025
by Georgia C. Ravitz, Shari Esfahani, Stephen Thau, Thora Johnson, Jeremy D. Sherer and Amy M. Joseph
2 minute read | January.13.2025
The FDA issued draft guidance on assessing AI model credibility for drug safety, effectiveness, and quality in regulatory decisions.
by Georgia C. Ravitz, Shari Esfahani, Stephen Thau, Thora Johnson, Jeremy D. Sherer and Amy M. Joseph
3 minute read | January.07.2025
14 minute read | December.20.2024
Healthtech Horizons: Navigating Regulation, Investment, and Strategy in a Transforming Market
28 minute read | October.07.2024
by Stephen Thau and Mike O'Donnell
3 minute read | September.26.2024
by Stephen Thau and David Sharrow
4 minute read | September.23.2024
21 minute read | June.26.2024
by Stephen Thau, Paul F. Rugani and Nina Ganti
1 minute read | April.09.2024
Companies should review insider-trading policies after an SEC enforcement action put "shadow trading" in the spotlight.
25 minute read | February.26.2024
Women's & Reproductive Health
by Stephen Thau, Albert Vanderlaan and George Pothoulakis
6 minute read | January.30.2024
Reverse mergers have helped biotech companies access public markets, but recent SEC positions are threatening that path to going public.
by David Rhinesmith, Thora Johnson, Stephen Thau and Tony Chan
4 minute read | November.10.2023